Fundraising Fox
/Companies
Sign in

Nervonik

21 employees on LinkedIn · 8 known investors

Find your way into Nervonik

Sign up to see every warm intro you have to Nervonik

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nervonik team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation. The systems focus on connectivity, wearability, lead stability, and durability for medical device applications.

HardwareHealthtechMedical Devices

Investors · 8

Joyance Partnerslisted by Joyance PartnersBerlin
Lumira Ventureslisted by Lumira VenturesToronto · $1M – $10M

How we know: Lumira Ventures's portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto

How we know: ShangBay Capital LLC's portfolio page · prnewswire.com · Not right? Tell us

US Venture Partnerslisted by US Venture PartnersMenlo Park · $500K – $10M

How we know: US Venture Partners's portfolio page · a partner's Signal profile · finance.yahoo.com · Not right? Tell us

Amzak HealthreportedNew York

How we know: prnewswire.com · Not right? Tell us

U.S. Venture PartnersreportedMinneapolis

How we know: prnewswire.com · Not right? Tell us

Also in the syndicate · 1

Elevage Medical Technologies

Funding

SEC filings, press & company announcements

$65.5M disclosed across 2 rounds · 2025–2026

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Neuraptive TherapeuticsNeuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.
NeuroBionicsNeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Companies working in the same space as Nervonik.

In the news

Nervonik Raises $52.5M to Advance Smart Neuromodulation Implants | citybizcitybiz.co · Apr 2026Nervonik Raises $52.5M in Series B Fundingfinsmes.com · Apr 2026Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Reliefprnewswire.com · Mar 2025

Frequently asked questions

What does Nervonik do?
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation. The systems focus on connectivity, wearability, lead stability, and durability for medical device applications.
Who are Nervonik's investors?
Nervonik's investors include Foothill Ventures, Joyance Partners, Lumira Ventures, ShangBay Capital LLC, US Venture Partners, Amzak Health, U.S. Venture Partners.
How much funding has Nervonik raised?
Nervonik has disclosed $65.5M raised across 2 rounds.